5244 Participants Needed

Stepped Care Suicide Prevention for Youth

(STARRS-PC Trial)

Recruiting at 18 trial locations
CF
PD
Overseen ByPriyanka Desirazu, MSE
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Cynthia Fontanella
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Suicide is the second leading cause of death among young people aged 12-17 years in the United States, yet many youth at risk for suicide are not identified or go untreated. Stepped care approaches have been shown to be effective at reducing suicide risk in clinical settings, including primary care. The goal of this hybrid I stepped wedge effectiveness-implementation study is to test the effectiveness of a population-based quality improvement (QI) intervention, entitled STARRS-PC (Stepped Approach to Reducing Risk of Suicide in Primary Care) compared to treatment as usual (TAU), in reducing the risk of suicidal behavior among youth in the pediatric primary care setting. STARRS-PC implements a clinical pathway for youth at elevated risk for suicide in pediatric primary care clinics. Clinical pathways are tools used by health professionals to guide evidence-informed practice. The STARRS-PC pathway consists of three evidence-based suicide clinical care processes: risk detection, assessment and triage, and, if needed, follow-up transitional care. STARRS-PC is guided by the Practical, Robust Implementation, and Sustainability Model (PRISM), which allows for the study of factors that influence effective implementation of the suicide prevention clinical pathway and is focused on scalability. The main questions the study aims to answer are: * Will STARRS-PC be more effective than TAU at reducing the rate of suicide attempt at 12 months post-baseline (primary outcome)? * Will STARRS-PC be more effective than TAU at reducing suicidal ideation and non-suicidal self-injury, and improving family satisfaction at 12 months post-baseline (secondary outcomes)? * What are the barriers and facilitators of effective implementation and sustainability of STARRS-PC?

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. However, it mentions that youth receiving medication for physical or psychiatric conditions can participate, so it seems likely you can continue your current medications.

What data supports the effectiveness of the treatment Stepped Approach to Reducing Risk of Suicide in Primary Care (STARRS-PC)?

Research shows that primary care is a key setting for identifying and managing suicide risk, and engaging primary care professionals in suicide prevention can be beneficial. Programs like SUPRANET have shown that training primary care professionals improves their ability to apply suicide prevention practices, suggesting that similar approaches in STARRS-PC could be effective.12345

Is the Stepped Care Suicide Prevention for Youth treatment safe for humans?

The available research does not provide specific safety data for the Stepped Care Suicide Prevention for Youth treatment, but it highlights the importance of training primary care professionals in suicide prevention, which is generally considered safe and beneficial for improving care.12678

How is the Stepped Approach to Reducing Risk of Suicide in Primary Care (STARRS-PC) treatment different from other suicide prevention treatments?

STARRS-PC is unique because it uses a stepped care approach, which means it provides different levels of treatment intensity based on the individual's needs, starting with the least intensive and moving to more intensive options if necessary. This approach is tailored to be delivered in primary care settings, making it more accessible and integrated into regular healthcare visits, unlike some other treatments that may require specialized settings.19101112

Research Team

JH

Jennifer Hughes, PhD, MPH

Principal Investigator

Abigail Wexner Research Institue at NCH

CF

Cynthia Fontanella, PhD

Principal Investigator

Abigail Wexner Research Institute at NCH

JB

Jeffrey Bridge, PhD

Principal Investigator

Abigail Wexner Research Institute at NCH

AK

Alex Kemper, MD, MPH, MS

Principal Investigator

Abigail Wexner Research Institute at NCH

Eligibility Criteria

This trial is for young people aged 12-17 who are at risk of suicide and receive care at one of the participating primary care clinics. It includes those with or without mental health issues, as well as those with physical illnesses or on medication, provided they meet other study criteria.

Inclusion Criteria

Providers must work with patients at one of the participating PCCs.
I am a young person with another illness or condition but still fit the study's main requirements.
I am between 12-17 years old, at risk for suicide, and receive care at a participating site.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

TAU (Treatment As Usual)

Participants receive usual and customary care, establishing baseline rates of suicide risk screening and detection

6-26 months

Intervention

Implementation of the STARRS-PC clinical pathway, including universal screening and risk assessment for suicide

11-30 months
Multiple assessments at baseline, 3, 6, and 12 months

Sustainability

Sites work on maintaining or improving gains made during the intervention phase

6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 months
Follow-up assessments at 3, 6, and 12 months

Treatment Details

Interventions

  • Stepped Approach to Reducing Risk of Suicide in Primary Care
Trial Overview The STARRS-PC program, a quality improvement intervention aimed at reducing suicide risk in youth through a clinical pathway involving risk detection, assessment and triage, and follow-up care. The effectiveness will be compared to usual treatment over a period of 12 months.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: STARRS-PCExperimental Treatment1 Intervention
Intervention consists of implementation of clinical pathway for youth suicide risk
Group II: Treatment As UsualActive Control1 Intervention
Treatment as Usual

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cynthia Fontanella

Lead Sponsor

Trials
1
Recruited
4,600+

Holzer Gallipolis

Collaborator

Holzer Jackson

Collaborator

Holzer Athens

Collaborator

Eastglen Pediatrics

Collaborator

Signature Health Ashtabula

Collaborator

Signature Health Willoughby

Collaborator

Signature Health Painesville

Collaborator

AxessPointe - Arlington

Collaborator

Dayton Children's Hospital

Collaborator

Trials
13
Recruited
5,029,000+

Findings from Research

Implementing brief standardized screening for suicide risk in pediatric primary care significantly increased the detection rates of suicidal youth by 392% across three clinics, demonstrating its efficacy in identifying at-risk adolescents.
The increase in detection rates was sustained over six months and led to a corresponding rise in referral rates to outpatient behavioral health care, highlighting the importance of early intervention in preventing serious suicide attempts.
Standardized screening for suicidal adolescents in primary care.Wintersteen, MB.[2022]
The SUPRANET program in the Netherlands provided valuable training for primary care professionals (PCPs) in suicide prevention, but PCPs faced challenges such as self-perceived incompetence and heavy workloads that hindered their ability to assess suicide risk effectively.
While the training was well-received, the study highlighted the need for better collaboration between PCPs and specialized mental health services to enhance suicide prevention efforts, indicating that education alone is not enough to improve care for suicidal patients.
Engaging primary care professionals in suicide prevention: A qualitative study.Elzinga, E., de Kruif, AJTCM., de Beurs, DP., et al.[2022]
In a study of 200 adolescents aged 12-20 who screened positive for suicidal risk in primary care, only 19.5% were deemed concerning by their physicians, highlighting a gap in recognition of serious risk factors.
Follow-up care for these adolescents was inconsistent, with only 13% being asked about weapons in the home and 7% about having a safety plan, indicating a need for improved guidelines in primary care settings for managing youth suicide risk.
Adolescent suicide assessment and management in primary care.Aalsma, M., Keys, J., Ferrin, S., et al.[2023]

References

Standardized screening for suicidal adolescents in primary care. [2022]
Engaging primary care professionals in suicide prevention: A qualitative study. [2022]
Adolescent suicide assessment and management in primary care. [2023]
Suicide risk in primary care: identification and management in older adults. [2022]
Implementing Suicide Risk Screening in a Pediatric Primary Care Setting: From Research to Practice. [2023]
Can routine Primary Care Records Help in Detecting Suicide Risk? A Population-Based Case-Control Study in Barcelona. [2022]
The Development of a Brief Suicide Screening and Risk Assessment Training Webinar for Rural Primary Care Practices. [2020]
Tailored Activation of Middle-Aged Men to Promote Discussion of Recent Active Suicide Thoughts: a Randomized Controlled Trial. [2023]
The effectiveness of suicide prevention delivered by GPs: A systematic review and meta-analysis. [2022]
Suicide prevention in primary care: General practitioners' views on service availability. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
From prototype to product: development of a primary care/internet based depression prevention intervention for adolescents (CATCH-IT). [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Confidential Survey Into Southwestern Ontario Suicide: Implication for Primary Care Practice. [2022]